Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2021-03-26 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20210326 - Acquisitions and Disposals of own shares.pdf
Transaction in Own Shares Classification · 99% confidence The document explicitly details the 'Acquisitions of own shares' and 'Disposal of own shares' conducted by UCB SA/NV under its Share Repurchase Program 2021, providing transaction dates, volumes, and prices. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is Transaction in Own Shares (POS). The document length is moderate (4069 chars), and it is a direct disclosure, not an announcement of a report.
2021-03-26 English
20210326 - Rachat et Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Rachat d'actions propres et aliénation d'actions propres" (Share repurchase and disposal of own shares). It details the number of shares repurchased by UCB on Euronext Bruxelles between March 19 and March 25, 2021, and the number of shares alienated (disposed of) following employee stock option exercises. This activity directly relates to the company managing its own stock holdings, which corresponds precisely to the definition of 'Transaction in Own Shares'. The code for this is POS.
2021-03-26 French
20210326 - Verwerving en vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 98% confidence The document text is titled "Verwerving en vervreemding van eigen aandelen" (Acquisition and disposal of own shares) and details specific transactions where UCB NV bought back its own shares (Aandelen Inkoopprogramma 2021) and disposed of shares related to employee incentive plans, including dates and prices. This directly relates to the company's share capital management and treasury activities. The filing category 'Transaction in Own Shares' (POS) is the most precise fit for reporting share repurchases and disposals of treasury stock. The document is a direct report of these transactions, not an announcement of a report, and its length (4312 chars) is substantial enough to be the report itself.
2021-03-26 Dutch
Remuneration Policy 2021 Final post GNCC_TO BE PUBLISHED_NL.pdf
Remuneration Information Classification · 98% confidence The document is titled "UCB Bezoldigingsbeleid 2021" (UCB Remuneration Policy 2021) and extensively details the compensation philosophy, principles, and specific remuneration structures for the Board of Directors and the Executive Committee. It discusses fixed pay, variable pay, long-term incentives, shareholder voting on the policy (scheduled for April 29, 2021), and governance oversight by the GNCC (Governance, Nomination & Remuneration Committee). This content directly relates to the compensation and remuneration practices of the company's leadership, which aligns perfectly with the definition of Remuneration Information (DEF 14A), which covers compensation for top executives and directors. Although it is a policy document, its core subject matter is executive and director compensation disclosure, making DEF 14A the most specific fit over general Governance (CGR) or Shareholder Voting (DVA).
2021-03-26 Dutch
NBB_0019_31.12.2020_FR Final (ucb.com).pdf
Annual Report Classification · 100% confidence The document is a formal 'Comptes Annuels' (Annual Accounts) filing for UCB SA, a Belgian company. It includes detailed balance sheet data, identification of directors, and auditor information for the fiscal year 2020. As it contains comprehensive financial statements for a full fiscal year, it is classified as an Annual Report (10-K equivalent in this context). FY 2020
2021-03-26 French
UCB NV - RC 31122020 - NL.pdf
Audit Report / Information Classification · 98% confidence The document is titled "Verslag van de commissaris aan de algemene vergadering van aandeelhouders over de jaarrekening voor het boekjaar afgesloten op 31 december 2020" (Report of the Commissioner to the General Meeting of Shareholders on the annual accounts for the financial year ended December 31, 2020). This document explicitly contains the auditor's opinion ('Oordeel zonder voorbehoud' - Unqualified opinion) on the annual financial statements ('jaarrekening'). This structure—a formal report from an external auditor/commissioner addressing the shareholders regarding the annual accounts—is characteristic of an Audit Report or Information filing, distinct from the full Annual Report (10-K) itself, although it is a key component of the annual reporting cycle. Given the specific focus on the audit opinion and the reference to the 'jaarrekening' (annual accounts), the most appropriate classification is 'AR' (Audit Report / Information). It is not the 10-K (the full annual report) nor is it a mere announcement of a report (RPA/RNS). FY 2020
2021-03-26 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.